METHOTREXATE INJECTION USP
PFIZER CANADA ULC
Quick answers
Is there a shortage of METHOTREXATE INJECTION USP in Canada?
No. There is no current shortage of METHOTREXATE INJECTION USP 10MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
METHOTREXATE TABLETS, USP
PFIZER CANADA ULC
PMS-METHOTREXATE INJECTION
PHARMASCIENCE INC
METHOTREXATE INJECTION USP
PFIZER CANADA ULC
METHOTREXATE INJECTION BP
ACCORD HEALTHCARE INC
METOJECT SUBCUTANEOUS
MEDEXUS PHARMACEUTICALS INC.
METHOTREXATE INJECTION, BP
PHARMASCIENCE INC
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02182947
Strength
10MG
Dosage Form
SOLUTION
Route
INTRAVENOUS INTRATHECAL INTRAMUSCULAR INTRA-ARTERIAL INTRACEREBROVENTRICULAR
Compare with another product →
Shortage History
Other Products from PFIZER CANADA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 02511053
40MG · DIN 02511045
20MG · DIN 02511061
DIN 02544040
5MG · DIN 01947664
10MG · DIN 01947672
20MG · DIN 01947680
40MG · DIN 01947699
DIN 02237367
DIN 02237368
DIN 02237369
50MG · DIN 02401347